Yes, Semaglutide is patented. It is patented by Novo Nordisk under several brand names, including Ozempic and Wegovy. The patent for Semaglutide is held until 2032, ensuring that Novo Nordisk retains exclusive rights to produce and sell the drug until then 1 2.
